Comprehensive quantitative proteomic profiling of the pharmacodynamic changes induced by MLN4924 in acute myeloid leukemia cells establishes rationale for its combination with azacitidine

V. Visconte, S. T. Nawrocki, C. M. Espitia, K. R. Kelly, A. Possemato, S. A. Beausoleil, Y. Han, H. E. Carraway, A. Nazha, A. S. Advani, J. P. Maciejewski, M. A. Sekeres, J. S. Carew

Research output: Contribution to journal › Letter › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Comprehensive quantitative proteomic profiling of the pharmacodynamic changes induced by MLN4924 in acute myeloid leukemia cells establishes rationale for its combination with azacitidine'. Together they form a unique fingerprint.